Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)

Abstract Background Febrile Urinary Tract Infection (FUTI) is frequently treated initially with intravenous antibiotics, followed by oral antibiotics guided by clinical response and bacterial susceptibility patterns. Due to increasing infection rates with multiresistant Enterobacteriaceae, antibioti...

Full description

Bibliographic Details
Main Authors: Thijs ten Doesschate, Suzan P. van Mens, Cees van Nieuwkoop, Suzanne E. Geerlings, Andy I. M. Hoepelman, Marc J. M. Bonten
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Infectious Diseases
Subjects:
Fosfomycin-trometamol
Urinary tract infection
Scherichia coli
Antibiotic treatment
Randomized clinical trial
Online Access:http://link.springer.com/article/10.1186/s12879-018-3562-2

Internet

http://link.springer.com/article/10.1186/s12879-018-3562-2

Similar Items